NCT07330921

Brief Summary

Problems with postural control cause difficulties in children's motor development, leading to significant structural and functional complications, including pelvic obliquity, scoliosis, and asymmetries in both active and passive ranges of motion. All these difficulties affecting posture control have a negative impact on children's functional autonomy and independent participation in their daily activities, as well as on their interaction with different environments, mainly family, social, and educational. In view of this situation, the 3D Adaptive Sitting System "SSAP3D", a 3D pelvic ser with a self-extracting abductor cushion, is proposed as an alternative. The main objective is to develop and test a novel 3D-printed adaptive seating system, called SSAP3D, tailored to individual needs of children with Neuromotor Dysfunction, to assess whether it promotes the functional performance of children in their daily and meaningful activities. A secondary objective is to analyze whether the use of SSAP3D promotes the children's participation in different environments compared to a conventional seated system. The sample is estimated at 12 children, all of them were between 2-6 years old and with Neuromotor Dysfunction from early attention centers, as well as from private rehabilitation centers or associations. The intervention program will be the same for each participant, but in different temporal order. 6 children will use during the first 6 weeks the 3D seat and the following 6 weeks their usual seating system; the others 6 children inverted order. The 3D seat will be made individually for each child. The device will be delivered 3 weeks after the scanning-data collection accompanied by guidelines for use. There will be 2 online follow-up sessions. Hypothesis: the implementation of the SSAP3D allows to ensure the postural requirements of children with Neuromotor Dysfunction and to favor their functional performance in daily and meaningful activities at home, at school and in their community. In addition, it will have a positive impact on the quality of life perceived by the families related to the characteristics of the seat.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Dec 2025Oct 2026

First Submitted

Initial submission to the registry

September 22, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

December 13, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

January 9, 2026

Status Verified

November 1, 2025

Enrollment Period

8 months

First QC Date

September 22, 2025

Last Update Submit

December 29, 2025

Conditions

Keywords

PerformanceChildrenSeating System3D TechnologyQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Performance

    Change in the score on the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). The PEDI-CAT is a computerized and adaptive questionnaire completed by the family that measures the child's functional performance in the areas of activities of daily life, mobility, social/cognitive function and responsibility in complex daily tasks. In addition, in children with Neuromotor Dysfunction, the PEDI-CAT has been shown to be a valid instrument to measure functional ability. 30-70: Considered the expected range for age, indicating normal functional capacity. \< 30: Suggests lower than expected functional capacity for age.

    from enrollment to the end of intervention, as in the two-follow-up assessment, assessed up to 9 months

Secondary Outcomes (7)

  • Postural control

    from enrollment to the end of intervention, as in the two-follow-up assessment, assessed up to 9 months

  • Functionality of upper extremity

    from enrollment to the end of intervention, as in the two-follow-up assessment, assessed up to 9 months

  • Achievement of Functional goals

    from enrollment to the end of intervention, as in the two-follow-up assessment, assessed up to 9 months

  • Participation in different environments

    from enrollment to the end of intervention, as in the two-follow-up assessment, assessed up to 9 months

  • Quality of Life

    from enrollment to the end of intervention, as in the two-follow-up assessment, assessed up to 9 months

  • +2 more secondary outcomes

Study Arms (1)

SSAP3D Intervention

EXPERIMENTAL

Participants will use the SSAP3D during the whole day by the child and the family for 6 weeks. At the beginning of the study, will carry out a session for taking body measurements and collecting data through the scanning of the participant. From this data collection, the SSAP3D will be digitally created. After all the necessary modifications have been made, the seat will be printed using FDM 3D Printer. Once the printing is finished, the removable systems and padding will be adjusted and placed by the designed interlocking systems. Three weeks after the data collection session, the SSAP3D will be delivered to the family and the 6-weeks intervention will begin. The correct elaboration of the device will be checked. Also, basic guidelines on the correct use of the seat, moments of use and maintenance of the seat will be explained to both the child and the families. This information will also be communicated to the school staff and to the different early care centers they attend.

Device: SSAP3D Intervention

Interventions

The intervention is the same for the whole sample but with deferent sequences: group 1 will perform the intervention following the sequence "SSAP3D + conventional system" and group 2 will perform the intervention with the opposite sequence, "conventional system + SSAP3D". Both groups will use 6 weeks the SSAP3D and 6 weeks the conventional system. During the 6 weeks of intervention using SSAP3D, 2 online follow-up sessions will be carried out with the family (weeks 6 and 8 for group 1; weeks 9 and 11 for group 2) with the aim of supervising the correct use and maintenance of the seat, as well as resolving possible doubts and/or the need to make anu modifications or adjustments to the seat, both in the family and school environment of the participant.

SSAP3D Intervention

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Medical Situation of Neuromotor Disfunction
  • Be user of some type of adapted seating system
  • Age between 2-6 years
  • Have head control levels of 3 to 8 on the Level of Sitting Scale (LSS)
  • Be able to maintain a standing position for at least 10 seconds, with or without external assistance.

You may not qualify if:

  • Presenting moderate or severe cognitive impairment, which generates significant difficulties in understanding the instructions given by the evaluator
  • Having suffered a traumatic injury o surgical process in the 6 months prior to the start of the study or during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AIDIMO (Asociación para la Investigación en la Discapacidad Motriz)

Zaragoza, Zaragoza, 50011, Spain

Location

Study Officials

  • Sandra Calvo, PhD

    Universidad de Zaragoza

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Daniel Rubio, PhD Student

CONTACT

Sandra Calvo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single Group Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd

Study Record Dates

First Submitted

September 22, 2025

First Posted

January 9, 2026

Study Start

December 13, 2025

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

January 9, 2026

Record last verified: 2025-11

Locations